← All Sponsors
SPONSOR

Tom Appleton

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Inflammatory ArthritisImmune-related Adverse Event
NCT06037811 Phase 2
Recruiting

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Inflammatory Arthritis
Canada View Trial →